Aeroflot Oao

◆英語タイトル:Aeroflot Oao - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY2994
◆発行会社(調査会社):MarketLine
◆発行日:2019
◆ページ数:49
◆レポート言語:
◆レポート形式:PDF
◆納品方法:E
◆対象地域:
◆産業分野:Transport and Logistics
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site LicenseUSD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide LicenseUSD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Aeroflot Oao – Strategy, SWOT and Corporate Finance Report
Summary

Aeroflot Oao – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Aeroflot OAO (Aeroflot) is a national air carrier group. It provides passenger and cargo air transportation services in domestic and international markets. The group also offers airline catering services. Aeroflot, through its affiliates, operate cargo-handling services, fueling services and duty-free retail businesses in airports. The group includes airlines such as Aeroflot, Rossiya, Pobeda and Aurora, which operate air carriers to multiple destinations across the world. Its fleet includes aircraft for short-, medium- and long-haul operations. Aeroflot is a member of SkyTeam alliance and operates its fleet of Airbus, Boeing and SukhoiSuperJet from its hub at Sheremetyevo Airport in Moscow. Aeroflot is headquartered in Moscow, Russia.

Scope

- Detailed information on Aeroflot Oao required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Aeroflot Oao in the form of a SWOT analysis
- An in-depth view of the business model of Aeroflot Oao including a breakdown and examination of key business segments
- Intelligence on Aeroflot Oao’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Aeroflot Oao, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Aeroflot Oao and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Aeroflot Oao as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Aeroflot Oao’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Aeroflot OAO: Company Overview
Aeroflot OAO: Overview and Key Facts
Aeroflot OAO: Overview
Aeroflot OAO: Key Facts
Aeroflot OAO: Key Employees
Aeroflot OAO: Key Employee Biographies
Aeroflot OAO: Major Products and Services
Aeroflot OAO: Company History
Aeroflot OAO: Management Statement
Aeroflot OAO: Locations and Subsidiaries
Aeroflot OAO: Key Competitors
Aeroflot OAO: Company Analysis
Aeroflot OAO: Business Description
Aeroflot OAO: SWOT Analysis
Aeroflot OAO: SWOT Overview
Aeroflot OAO: Strengths
Aeroflot OAO: Weaknesses
Aeroflot OAO: Opportunities
Aeroflot OAO: Threats
Aeroflot OAO: Corporate Financial Deals Activity
Aeroflot OAO: Financial Deals Overview
Aeroflot OAO: Targets and Partners
Aeroflot OAO: Top Deals 2015 – 2019YTD*
Aeroflot OAO: Partnership
Aeroflot OAO: Recent Developments
Aeroflot OAO: News and Events Summary
Aeroflot OAO: Business Expansion
Aeroflot OAO: Contracts
Aeroflot OAO: Financial Deals
Aeroflot OAO: Financial Performance
Aeroflot OAO: Regulatory and Legal Events
Aeroflot OAO: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Aeroflot OAO: Key Facts
Table 2: Aeroflot OAO: Key Employees
Table 3: Aeroflot OAO: Company History
Table 4: Aeroflot OAO: Locations and Subsidiaries
Table 5: Aeroflot OAO: Key Competitors
Table 6: Aeroflot OAO: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Aeroflot OAO: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Aeroflot OAO: Targets and Partners
Table 9: Aeroflot OAO: Top Deals 2015 - 2019YTD*
Table 10: Aeroflot OAO: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 11: Aeroflot OAO: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 12: Aeroflot OAO: News and Events Summary
Table 13: Aeroflot OAO: Business Expansion
Table 14: Aeroflot OAO: Contracts
Table 15: Aeroflot OAO: Financial Deals
Table 16: Aeroflot OAO: Financial Performance
Table 17: Aeroflot OAO: Regulatory and Legal Events
Table 18: Aeroflot OAO: Strategy and Operations

★海外企業調査レポート[Aeroflot Oao]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Robert Bosch GmbH:企業の戦略・SWOT・財務分析
    Robert Bosch GmbH - Strategy, SWOT and Corporate Finance Report Summary Robert Bosch GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Step Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary Step Pharma SAS (Step Pharma) is a biotechnology company, which strives to discover and develop proprietary small molecule medicines for the treatment of auto-immune diseases. The company is developing a new class of oral nucleotide synthesis inhibitors against cytidine triphosphate synthase …
  • Peptimimesis SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Peptimimesis SAS (Peptimimesis) is a biopharmaceutical company that discovers and develops transmembrane therapeutic peptides. The company’s proprietary platform delivers a set of drug candidates that act on strategic targets in the field of immuno-oncology, oncology and immune diseases. Its …
  • P2P Global Investments PLC (P2P):企業の財務・戦略的SWOT分析
    P2P Global Investments PLC (P2P) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • LifePoint Health Inc (LPNT):製薬・医療:M&Aディール及び事業提携情報
    Summary LifePoint Health Inc (LifePoint) is a healthcare service provider which operates community hospitals, physician practices, outpatient centers, post-acute facilities and regional health systems. The company along with its subsidiaries delivers a range of medical and surgical services to non-u …
  • Mediobanca Private Banking:企業の戦略・SWOT・財務情報
    Mediobanca Private Banking - Strategy, SWOT and Corporate Finance Report Summary Mediobanca Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Pt Bank Central Asia Tbk:企業の戦略・SWOT・財務分析
    Pt Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Hinduja Global Solutions Ltd (HGS):企業の財務・戦略的SWOT分析
    Hinduja Global Solutions Ltd (HGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • GamaMabs Pharma SA-製薬・医療分野:企業M&A・提携分析
    Summary GamaMabs Pharma SA (GamaMabs) is a clinical-stage immuno-oncology company developing optimized therapeutic antibodies for the treatment of cancer. Its lead product candidate GM102, is an anti-AMHR2, Emabling engineered humanized mAb product targeting the receptor of anti-Mullerian hormone (A …
  • American CryoStem Corp (CRYO):企業の財務・戦略的SWOT分析
    Summary American CryoStem Corp (American CryoStem), formerly Advanced Wound Technologies-MidAtlantic LLC is a manufacturer, developer, and marketer of life-enhancing and stem cell technologies. The company offers products such as adipose derived stem cells, tissue collection and transportation produ …
  • Petrolympic Ltd (PCQ):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrolympic Ltd (Petrolympic) is an oil and gas exploration and development company that acquires, explores and develops light crude oil and natural gas in North America. The company holds interests in conventional natural gas and light oil projects in Gaspe Peninsula of Quebec. It holds int …
  • Quantum Fuel Systems LLC:企業の戦略的SWOT分析
    Quantum Fuel Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Biomerica Inc (BMRA):企業の財務・戦略的SWOT分析
    Biomerica Inc (BMRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nimir Industrial Chemical Ltd (NICL):企業の財務・戦略的SWOT分析
    Summary Nimir Industrial Chemical Ltd (NICL) is a chemical company that manufactures and distributes oleo chemicals and chlor alkali. The company offers products such as stearic acid, soap noodles, glycerin, caustic soda, sodium hypochlorite, and hydrochloric acid, among others. It also provides raw …
  • Broadridge Financial Solutions, Inc.:戦略・SWOT・企業財務分析
    Broadridge Financial Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Broadridge Financial Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Opthea Ltd (OPT)-製薬・医療分野:企業M&A・提携分析
    Summary Opthea Ltd (Opthea), formerly Circadian Technologies Ltd is a provider of research and development of angiogenesis and vascular leakage-based treatments for cancer focusing on vascular endothelial growth factors. The company’s pipeline products comprise VEGF-C, VEGF-D and VEGFR-3. Opthea’s d …
  • Tapestry, Inc.:企業の戦略・SWOT・財務情報
    Tapestry, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tapestry, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Imperial Metals Corporation:企業の戦略・SWOT・財務情報
    Imperial Metals Corporation - Strategy, SWOT and Corporate Finance Report Summary Imperial Metals Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • United Therapeutics Corporation:企業の戦略・SWOT・財務分析
    United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report Summary United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • NGM Biopharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NGM Biopharmaceuticals Inc (NGM Bio) is a clinical-stage biopharmaceutical company that develops pipeline of biological therapeutics for the treatment of cardio-metabolic, immuno-oncology, retinal and liver diseases. The company’s pipeline products include NGM282, NGM386, NGM395, NGM621, NGM …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆